Literature DB >> 19088452

The peptide transporter PEPT2 is targeted by the protein kinase SGK1 and the scaffold protein NHERF2.

Christoph Boehmer1, Monica Palmada, Fabian Klaus, Sankarganesh Jeyaraj, Ricco Lindner, Jorg Laufer, Hannelore Daniel, Florian Lang.   

Abstract

PEPT1 and PEPT2 are members of the family of proton-dependent oligopeptide transporters that mediate electrogenic uphill transport of small peptides and peptidomimetics into a variety of cells. Kinetic properties and substrate recognition sites of those transporters have been well defined previously. Little is known, however, about regulation of those transporters. Both PEPT isoforms contain putative phosphorylation sites for the serum and glucocorticoid inducible kinase SGK1 and a C-terminal PDZ binding motif that might be recognized by PDZ domains of the Na(+)/H(+) exchanger regulatory factors NHERF1 and NHERF2. Thus, the present study attempted to clarify the role of SGK1 and NHERFs in the modulation of PEPT isoforms. Expression studies in Xenopus oocytes with subsequent electrophysiology and immunoassays revealed that SGK1 and NHERF2, but not the NHERF1 isoform specifically enhance PEPT2 function and surface abundance. The kinase is effective through phosphorylation of (185)Ser within the SGK1 consensus site, since disruption of this site prevented transporter modulation by the kinase. NHERF2 failed to regulate the C-terminal deletion mutant (PEPT2DeltaC) indicating that the C-terminal PDZ-binding motif in PEPT2 governs transport modulation by NHERF2. Coexpression of NHE3 stimulates PEPT2 activity to a similar extent as coexpression of NHERF2. Dynasore experiments demonstrated that SGK1 and NHERF2 activate PEPT2 by stabilizing the transporter at the cell surface. In conclusion, the present results reveal two novel PEPT2 posttranslational modulators, SGK1 and NHERF2, which might regulate transport of oligopeptides and peptidomimetic drugs. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19088452     DOI: 10.1159/000185554

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  23 in total

Review 1.  Significance of SGK1 in the regulation of neuronal function.

Authors:  Florian Lang; Nathalie Strutz-Seebohm; Guiscard Seebohm; Undine E Lang
Journal:  J Physiol       Date:  2010-06-07       Impact factor: 5.182

2.  Concerted actions of NHERF2 and WNK4 in regulating TRPV5.

Authors:  Haiyan Jing; Tao Na; Wei Zhang; Guojin Wu; Chuanyong Liu; Ji-Bin Peng
Journal:  Biochem Biophys Res Commun       Date:  2010-12-25       Impact factor: 3.575

3.  PKB/SGK-resistant GSK3 enhances phosphaturia and calciuria.

Authors:  Michael Föller; Daniela S Kempe; Krishna M Boini; Ganesh Pathare; Balasaheb Siraskar; Paola Capuano; Ioana Alesutan; Mentor Sopjani; Gerti Stange; Nilufar Mohebbi; Madhuri Bhandaru; Teresa F Ackermann; Martin S Judenhofer; Bernd J Pichler; Jürg Biber; Carsten A Wagner; Florian Lang
Journal:  J Am Soc Nephrol       Date:  2011-04-14       Impact factor: 10.121

4.  Regulation of the Ca(2+) channel TRPV6 by the kinases SGK1, PKB/Akt, and PIKfyve.

Authors:  Mentor Sopjani; Anja Kunert; Kamil Czarkowski; Fabian Klaus; Jörg Laufer; Michael Föller; Florian Lang
Journal:  J Membr Biol       Date:  2009-12-30       Impact factor: 1.843

Review 5.  Drug Transporters and Na+/H+ Exchange Regulatory Factor PSD-95/Drosophila Discs Large/ZO-1 Proteins.

Authors:  Dustin R Walsh; Thomas D Nolin; Peter A Friedman
Journal:  Pharmacol Rev       Date:  2015-07       Impact factor: 25.468

Review 6.  Serum- and glucocorticoid-inducible kinase 1 in the regulation of renal and extrarenal potassium transport.

Authors:  Florian Lang; Volker Vallon
Journal:  Clin Exp Nephrol       Date:  2011-11-01       Impact factor: 2.801

7.  SGK, renal function and hypertension.

Authors:  Florian Lang; Dan Yang Huang; Volker Vallon
Journal:  J Nephrol       Date:  2010 Nov-Dec       Impact factor: 3.902

Review 8.  Transcriptional and functional regulation of the intestinal peptide transporter PEPT1.

Authors:  Britta Spanier
Journal:  J Physiol       Date:  2013-08-19       Impact factor: 5.182

Review 9.  Loops and layers of post-translational modifications of drug transporters.

Authors:  Da Xu; Guofeng You
Journal:  Adv Drug Deliv Rev       Date:  2016-05-09       Impact factor: 15.470

Review 10.  Targeting SGK1 in diabetes.

Authors:  Florian Lang; Agnes Görlach; Volker Vallon
Journal:  Expert Opin Ther Targets       Date:  2009-11       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.